Kidney Cancer Clinical Trials

A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CDX-014

UPDATED

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

UPDATED

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90048

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

View More ▼

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Georgia

UPDATED

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Indiana

UPDATED

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Maryland

UPDATED

Baltimore Maryland 21287

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Baltimore Maryland 21287

A clinical research study of Nivolumab for the treatment of Clear Cell Renal Cell Carcinoma, Non-metastatic Stage II-IV

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating CDX-014

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston Massachusetts 02215

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Bevacizumab and Atezolizumab to evaluate Advanced Non-Clear Cell Kidney Cancer

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Bevacizumab and Atezolizumab to evaluate Advanced Non-Clear Cell Kidney Cancer

Michigan

UPDATED

Detroit Michigan 48201

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Missouri

UPDATED

St. Louis Missouri 63110

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New Jersey

New Brunswick New Jersey 08903

Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

New York

UPDATED

New York New York 10032

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

New York New York 10065

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

New York New York 10029

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New York New York 10065

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

North Carolina

UPDATED

Huntersville North Carolina 28078

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Ohio

Cleveland Ohio 44195

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Oregon

Portland Oregon 97213

A Phase 2 clinical study for patients with Renal Cell Carcinoma, Metastatic Renal Cancer (SBRT)

Pennsylvania

UPDATED

Pittsburgh Pennsylvania 15232

A clinical research study of CPI-444 and CPI-444 + atezolizumab

South Carolina

Greenville South Carolina 29605

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tennessee

Nashville Tennessee 37203

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Nashville Tennessee 37203

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Nashville Tennessee 37232-6307

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Texas

UPDATED

Dallas Texas 75251

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Dallas Texas 75239

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Houston Texas 77030

A clinical trial to evaluate treatments using Pazopanib, Temsirolimus, Quality of Life Assessment and Benadryl for patients with Kidney Cancer (RCC)

Houston Texas 77030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Houston Texas 77030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

View More ▼

Houston Texas 77030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Nivolumab, Bevacizumab and Ipilimumab for the treatment of Kidney Cancer, Metastatic Renal Cell Carcinoma (mRCC)

Houston Texas 77030

Patients are needed to participate in a clinical research study of Tremelimumab, Cryoablation and Long-Term Follow-Up to evaluate Kidney Cancer

San Antonio Texas 78229

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors